Nrc Health (NRC) Common Equity (2010 - 2026)

Nrc Health has disclosed Common Equity across 17 years of filings, most recently posting $13.5 million for Q1 2026.

• Common Equity for Q1 2026 came in at $13.5 million, down 54.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.5 million (down 54.52% YoY), and the FY2025 annual result was $14.0 million, down 55.28% from the prior year.
• Common Equity came in at $13.5 million for Q1 2026 at Nrc Health, down from $14.0 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $81.5 million in Q1 2022 to a low of $13.5 million in Q1 2026.
• The 5-year median for Common Equity is $40.2 million (2024), against an average of $46.2 million.
• Across the five-year window, Common Equity advanced 13.3% in 2023 and slumped 58.66% in 2025, its largest moves.
• Nrc Health's Common Equity stood at $72.0 million in 2022, then plunged by 32.04% to $49.0 million in 2023, then plunged by 36.1% to $31.3 million in 2024, then slumped by 55.28% to $14.0 million in 2025, then slipped by 3.54% to $13.5 million in 2026.
• The last three Common Equity figures came in at $13.5 million (Q1 2026), $14.0 million (Q4 2025), and $14.3 million (Q3 2025), per Business Quant data.